Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Alliance today announced a new direct-to-patient option for purchasing Eliquis ® (apixaban) via our Alliance’s patient resource Eliquis 360 Support. The offering provides an opportunity for uninsured, ...

Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...

WASHINGTON, DC / ACCESS Newswire / July 15, 2025 /FairWinds Partners, the world's leading domain name strategy consultancy, ...

I am pleased to welcome Corleen to Iovance at such an important stage in our first commercial launch,” said Frederick G. Vogt, Ph.D., J.D., Interim Chief Executive Officer, President and General ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

“My upcoming public hearing with Sen. (James) Skoufis will be an opportunity for PPL to speak to their leadership’s decisions ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Even as Apple faces mounting challenges — from AI stumbles to fading product innovation — the 64-year-old chief executive retains firm control.

I didn’t set out to build a global innovation network spanning 45 countries. Here are four lessons from my journey.

The House Judiciary Committee has subpoenaed Dr. Philip Dormitzer, a former Pfizer Inc. (NYSE:PFE) executive, in connection with an investigation into claims that the company intentionally delayed ...